Abstract:Objectives To examine the inhibitory effects of adenosine monophosphate-activated protein kinase (AMPK) activation on cardiomyocyte hypertrophy in vitro and to investigate the underlying molecular mechanisms. Methods Cultured neonatal rat cardiomyocytes were treated with the specific AMPK activator 5-aminoimidazole-4-carboxamide ribonu-cleoside (AICAR, 0.5 mmol/L) and the specific AMPK antagonist Compound C (1 μmol/L), and then stimulated with angiotensin II (Ang II, 1 μmol/L). The Muscle atrophy F-box (MAFbx)-small interfering RNA (siRNA) was transfected into cardiomyocytes using Lipofectamine 2000. The surface area of cultured cardiomyocytes was measured using planimetry. The protein degradation was determined using high performance liquid chromatogra-phy (HPLC). The expression of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), MAFbx, as well as the phosphorylation levels of AMPK and Forkhead box O 3a (FOXO3a), were separately measured using Western blot or real-time polymerase chain reaction. Results Activation of AMPK by AICAR inhibited Ang II-induced increase in cardiomyocyte area (P < 0.01 vs Ang II group), ANP and BNP protein expression (P < 0.01 vs Ang II group), as well as Ang II-induced decrease in protein degradation (P < 0.01 vs Ang II group). Compared with the control group, Ang II treatment significantly increased the p-FOXO3a level, whereas down-regulated MAFbx mRNA and protein expression levels in cultured cardiomyocytes (P < 0.01). Furthermore, AMPK activation decreased the p-FOXO3a level, increased the activity of transcription factor FOXO3a and up-regulated downstream atrogene MAFbx mRNA and protein expression (P < 0.05 vs Ang II group). Treatment of hypertrophied cardiomyocytes with Compound C blocked the effects of AMPK on cardiomyocyte hypertrophy and changes to the FOXO3a/MAFbx pathway (P < 0.05 vs Ang II + AICAR group). The effects of AICAR on cardiomyocyte hypertrophy were also blunted after MAFbx was silenced by transfection of cardiomyocytes with MAFbx-siRNA (P < 0.01 vs Ang II + AICAR group). Conclusions The present study demonstrates that AMPK activation inhibits cardiomyocyte hypertrophy by modulating the atrophy-related FOXO3a/MAFbx signaling pathway in vitro.

Muscarinic receptor activation of AMP-activated protein kinase inhibits orexigenic neuropeptide mRNA expression

Opposing neuropeptides control cAMP signalling to regulate satiety

Orexin-A Activates Hypothalamic AMP-Activated Protein Kinase Signaling Through a Ca2+-Dependent Mechanism Involving Voltage-Gated L-Type Calcium Channel

Muscle-selective knockout of AMPKα2 does not exacerbate diet-induced obesity probably related to altered myokines expression.

Inhibition of the AMP-activated Protein Kinase-Α2 Accentuates Agonist-Induced Vascular Smooth Muscle Contraction and High Blood Pressure in Mice.

Activation of AMPK Inhibits Cardiomyocyte Hypertrophy by Modulating of the FOXO1/MuRF1 Signaling Pathway in Vitro

Inhibition of Hypothalamic MCT4 and MCT1-MCT4 Expressions Affects Food Intake and Alters Orexigenic and Anorexigenic Neuropeptide Expressions

Cell autonomous regulation of the activation of AgRP neurons by the melanocortin-3 receptor

GW24-e2121 Adenosine Monophosphate-Activated Protein Kinase Attenuates Cardiomyocyte Hypertrophy Through Regulation of FOXO3a/MAFbx Signalling Pathway

Loss of AMP-Activated Protein Kinase-α2 Impairs the Insulin-Sensitizing Effect of Calorie Restriction in Skeletal Muscle

CaMK1D Signalling in AgRP Neurons Promotes Ghrelin-Mediated Food Intake

Glucose Alters Per2 Rhythmicity Independent of AMPK, Whereas AMPK Inhibitor Compound C Causes Profound Repression of Clock Genes and AgRP in mHypoE-37 Hypothalamic Neurons

Subthreshold activation of the melanocortin system causes generalized sensitization to anorectic agents in mice

Dynamic, sex‐ and diet‐specific pleiotropism in the PAC1 receptor‐mediated regulation of arcuate proopiomelanocortin and Neuropeptide Y/Agouti related peptide neuronal excitability by anorexigenic ventromedial nucleus PACAP neurons

Amino Acids Inhibit Agrp Gene Expression Via an Mtor-Dependent Mechanism

Activation of Calcium-Sensing Receptor in the Area Postrema Inhibits Food Intake via Glutamatergic and GABAergic Signaling Pathways

Mutual Effects of Orexin and Bone Morphogenetic Proteins on Catecholamine Regulation Using Adrenomedullary Cells

Evidence For The Role Of Ampk In Regulating Pgc-1 Alpha Expression And Mitochondrial Proteins In Mouse Epididymal Adipose Tissue

Melanin concentrating hormone projections to the nucleus accumbens enhance the reward value of food consumption and do not induce feeding or REM sleep

Amylin/Calcitonin Receptor–Mediated Signaling in POMC Neurons Influences Energy Balance and Locomotor Activity in Chow-Fed Male Mice

A neural basis for melanocortin-4 receptor-regulated appetite